hVIVO (LON:HVO) Shares Up 10% - Here's Why

hVIVO plc (LON:HVO - Get Free Report)'s stock price traded up 10% on Tuesday . The stock traded as high as GBX 22 ($0.27) and last traded at GBX 21.25 ($0.26). 7,804,669 shares changed hands during trading, an increase of 164% from the average session volume of 2,961,263 shares. The stock had previously closed at GBX 19.33 ($0.24).

hVIVO Price Performance

The stock has a market cap of £130.97 million, a price-to-earnings ratio of 641.67 and a beta of 0.97. The stock has a fifty day simple moving average of GBX 19.91 and a 200-day simple moving average of GBX 25.52. The company has a current ratio of 1.61, a quick ratio of 1.16 and a debt-to-equity ratio of 33.86.

hVIVO Company Profile

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.